Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_assertion type Assertion NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_head.
- NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_assertion wasGeneratedBy ECO_0000203 NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_provenance.
- NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_assertion wasDerivedFrom befree-20150227 NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_provenance.
- NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_assertion SIO_000772 23384775 NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_provenance.
- NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_assertion evidence source_evidence_literature NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_provenance.
- NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_assertion description "[Frequent outlier kinases in breast cancer included therapeutic targets like ERBB2 and FGFR4, distinct from MET, AKT2, and PLK2 in pancreatic cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP852941.RAFwAH6lwLRlCIkeBbXc7hJVreA65fg3DComGk40P5vss130_provenance.